Followers | 2 |
Posts | 1540 |
Boards Moderated | 0 |
Alias Born | 05/06/2017 |
Tuesday, May 30, 2023 1:16:40 PM
Source
https://finance.yahoo.com/news/imaginear-announces-closing-private-placement-120000273.html
May 29, 2023
ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality company that enables sports teams, brands and businesses to instantly create their own mobile phone immersive AR campaigns, is pleased to announced it closed a non-brokered private placement financing of 12,905,315 Units, at a price of $.033 per Unit for gross proceeds of $425,875.
Each Unit will be comprised of one common share and one non-transferable common share purchase warrant, with each Warrant entitling the holder to purchase one additional common share at a price of $0.05 for a period of thirty-six months from the closing of the Offering. In accordance with applicable Canadian securities laws, all securities issued pursuant to the private placement with a hold period of four months and one day from the date of issuance.
ImagineAR intends to use the net proceeds from the proposed private placement to enhance its SDK technology, sales, and marketing support, and develop AI integration proof of concept immersive AR activations.
ImagineAR SDK New Release
The Company is launching a new release of the "Drop-In" Native SDK (Software Development Kit) integration for IOS and Android mobile apps. This major release, currently scheduled for summer launch with the NFL Baltimore Ravens, will feature many new features/functions and an enhanced AR Scavenger Hunt.
"This significant SDK release makes it faster and economical for clients and partners to integrate our AR platform directly into their mobile app with reduced technical resources and timeframe",stated Alen Paul Silverrstieen, CEO of ImagineAR Inc.
Ferencvárosi Torna Club Flutter Integration
The Company has postponed the ImagineAR SDK Flutter integration for the Hungarian Soccer Champion Ferencvárosi Torna proof of concept. Technical resources had been allocated to complete the new "Drop-in" SDK to achieve the June deadline.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM